HTA Database - Search Results

Sort by Relevance

Search Results [15922 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Brentuximab vedotin in lymphomas
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Endoscopic radiofrequency ablation (Secca Procedure) for the treatment of fecal incontinence
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Elastomeric drug infusion pumps
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Autoantibody panel for autoimmune encephalitis
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	BAHA® bone-anchored hearing aid for the treatment of hearing loss
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Mutational screening of notch3 gene in the diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukocencephalopathy (CADASIL)
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Radioembolization and chemoembolization with drug-eluting microspheres for the treatment of liver tumors
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Hydrophobic acrylic intraocular lenses in cataract surgery due to uveitis
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Three-dimensional electroanatomical mapping in arrhythmia ablation
2016	Agency for Healthcare Research and Quality (AHRQ)	Omega-3 fatty acids and cardiovascular disease: an updated systematic review
2016	Agency for Healthcare Research and Quality (AHRQ)	Strategies to de-escalate aggressive behavior in psychiatric patients
2016	Health Quality Ontario (HQO)	Composite tissue transplant of hand or arm: a health technology assessment
2016	Health Quality Ontario (HQO)	Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment
2016	Health Quality Ontario (HQO)	Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment
2016	Health Quality Ontario (HQO)	Women's experiences of inaccurate breast cancer screening results: a systematic review and qualitative meta-synthesis
2016	Health Quality Ontario (HQO)	Fecal microbiota therapy for clostridium difficile infection: a health technology assessment
2016	Health Quality Ontario (HQO)	Composite tissue transplant of hand or arm: OHTAC recommendation
2016	Health Quality Ontario (HQO)	Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC recommendation
2016	Health Quality Ontario (HQO)	Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation
2016	Health Quality Ontario (HQO)	Fecal microbiota therapy for clostridium difficile infection: OHTAC recommendation
2016	NIHR Health Technology Assessment programme	Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation
2016	Agency for Healthcare Research and Quality (AHRQ)	Renal artery stenosis management strategies: an updated comparative effectiveness review
2016	NIHR Health Services and Delivery Research programme	Improving care for people with dementia: development and initial feasibility study for evaluation of life story work in dementia care
2016	HAYES, Inc.	DecisionDx-UM (Castle Biosciences Inc.)
2016	HAYES, Inc.	Epi proColon (Epigenomics Inc.)
2016	HAYES, Inc.	FoundationOne (Foundation Medicine Inc.)
2016	HAYES, Inc.	MammaPrint 70-Gene breast cancer recurrence assay (Agendia)
2016	HAYES, Inc.	Molecular intelligence (Caris Life Sciences)
2016	HAYES, Inc.	VeriStrat
2016	HAYES, Inc.	Catalys Precision Laser System (OptiMedica Corp.; Abbott Medical Optics) for cataract surgery
2016	HAYES, Inc.	Coflex Interlaminar Stabilization Device (Paradigm Spine LLC) for treatment of lumbar spinal stenosis
2016	HAYES, Inc.	EX-PRESS Glaucoma Filtration Device (Alcon Inc.) for treatment of open-angle glaucoma
2016	HAYES, Inc.	Iluvien (Fluocinolone Acetonide Intravitreal Implant; Alimera Sciences) for treatment of diabetic macular edema
2016	HAYES, Inc.	Infliximab (Remicade; Janssen Biotech Inc.) for first-line treatment of pediatric Crohn disease
2016	HAYES, Inc.	MarginProbe System (Dune Medical Devices) for intraoperative assessment of surgical margins in patients with breast cancer
2016	HAYES, Inc.	Noncontact low-frequency ultrasound using the MIST Therapy System (Celleration Inc.) for treatment of lower extremity arterial and diabetic foot ulcers
2016	HAYES, Inc.	Noncontact low-frequency ultrasound using the MIST Therapy System (Celleration Inc.) for treatment of venous leg ulcers
2016	HAYES, Inc.	PleurX peritoneal catheter for home management of malignant ascites
2016	HAYES, Inc.	Polidocanol endovenous microfoam (Varithena) 1% for treatment of varicose veins
2016	HAYES, Inc.	Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of chronic pain related to cancer or cancer treatment
2016	HAYES, Inc.	Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of pain not related to cancer
2016	HAYES, Inc.	Sebelipase Alfa (Kanuma) for treatment of lysosomal acid lipase deficiency
2016	HAYES, Inc.	Speech therapy for treatment of adults with primary progressive aphasia
2016	NIHR Health Technology Assessment programme	Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model
2016	NIHR Health Technology Assessment programme	A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study
2016	NIHR Health Services and Delivery Research programme	The use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial with embedded feasibility study
2016	HAYES, Inc.	Bronchial thermoplasty for treatment of asthma
2016	HAYES, Inc.	Comparative effectiveness of allogeneic hematopoietic stem cell transplant versus drug-based strategies for treatment of chronic myelogenous leukemia
2016	HAYES, Inc.	Comparative effectiveness of bioresorbable vascular scaffold stents versus other drug-eluting stents for the treatment of coronary artery disease
2016	HAYES, Inc.	Comparative effectiveness of cryoablation and radiofrequency ablation for atrial fibrillation
2016	HAYES, Inc.	Comparative effectiveness review of biolimus-eluting stents versus bare-metal stents and second-generation drug-eluting stents
2016	HAYES, Inc.	Comparative effectiveness review of everolimus- and zotarolimus-eluting stents for coronary artery disease
2016	HAYES, Inc.	Comparative effectiveness review of influence of pretransplant treatment and conditioning strategies on allogeneic stem cell transplant effectiveness for treatment of chronic myelogenous leukemia
2016	HAYES, Inc.	Comparative effectiveness review of the influence of stem cell source on allogeneic stem cell transplant effectiveness for treatment of chronic myelogenous leukemia
2016	HAYES, Inc.	Laparoscopic and open surgical repairs for treatment of athletic groin pain
2016	HAYES, Inc.	Noninvasive electrical bone growth stimulators for acute, delayed union, and nonunion fractures
2016	HAYES, Inc.	Optical Coherence Tomography (OCT) for plaque characterization and stent implantation
2016	HAYES, Inc.	Panniculectomy for treatment of symptomatic panniculi
2016	HAYES, Inc.	Percutaneous mechanical thrombectomy for deep vein thrombosis
2016	HAYES, Inc.	Percutaneous mechanical thrombectomy for pulmonary embolism
2016	HAYES, Inc.	Proton beam therapy for prostate cancer
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke. National Report: German Summary of the correspondent EUnetHTA Report]
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bevacizumab (Avastin®) in addition to standard chemotherapy for the first-line treatment of ovarian cancer
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Afatinib (Giotrif®) in patients with non-small cell lung cancer (NSCLC) who are refractory to erlotinib/gefitinib and afatinib monotherapy
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Drugs in oncology: an overview of benefit and refund practices in Europe]
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB). 2nd Update 2016]
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Screening, diagnostics and indication for occupational therapy in children and adolescents with Developmental Coordination Disorders]
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Leadless pacemakers for right ventricle pacing
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Single-step scaffold-based cartilage repair in the knee
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Radiofrequency denervation for sacroiliac and facet joint pain
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Upper airway stimulation for moderate-to-severe sleep apnea
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Magnetic sphincter augmentation device (MSAD) in patients with gastroesophageal reflux disease (GERD)
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Obinutuzumab (Gazyvaro®) in combination with bendamustine for the treatment of relapsed/refractory follicular lymphoma (FL)
2016	NIHR Horizon Scanning Centre (NIHR HSC)	ATIR101 for patients with haematological malignancy who are candidates for haematopoietic stem cell transplantation – adjunctive therapy
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Carfilzomib (Kyprolis) in combination with melphalan and prednisone for multiple myeloma – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Dabrafenib (Tafinlar) with trametinib (Mekinist) for BRAF V600 mutation positive melanoma – adjuvant therapy
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Lifitegrast for dry eye disease
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for gastric and gastroesophageal junction adenocarcinoma – third and fourth line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Ozanimod for relapsing remitting multiple sclerosis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Siponimod for secondary progressive multiple sclerosis
2016	NIHR Health Technology Assessment programme	ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis
2016	NIHR Health Services and Delivery Research programme	Transforming community health services for children and young people who are ill: a quasi-experimental evaluation
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparative effectiveness of carbapenems and alternative antibiotics for the treatment of bacteraemia and/or urinary tract infectious disease by Enterobacteriaceae producing extended-spectrum β-lactamase]
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Advantages of vestibular rehabilitation on the vestibular neuritis]
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on the effectiveness and needs of patient education in patients with rheumatoid arthritis]
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparison between ICPC (International Classification of Primary Care) classification and ICD (International Classification of Diseases) classification at primary care in Korea]
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Collaboration Research for development of Trustworthy Clinical Practice Guidelines and evaluation of implementation]
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[A health technology evaluation study for reviewing possibility of data linkage]
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Outpatient cardiac rehabilitation part VI: prospective multi-centre cohort study (comparing patients with and without phase III)]
2016	NIHR Health Services and Delivery Research programme	Health Equity Indicators for the English NHS: a longitudinal whole-population study at the small-area level
2016	NIHR Health Services and Delivery Research programme	Characterising the nature of primary care patient safety incident reports in the England and Wales National Reporting and Learning System: a mixed-methods agenda-setting study for general practice
2016	NIHR Public Health Research (PHR) programme	Development and evaluation of an intervention providing insight into the tobacco industry to prevent smoking uptake: a mixed-methods study
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Hepatitis C virus screening in hospitals]
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Atezolizumab (Tecentriq™) for the treatment of locally advanced and metastatic urothelial carcinoma.
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Venetoclax (Venclexta™) for the treatment of relapsed or refractory chronic lymphocytic leukaemia (CLL) with chromosome 17p deletion
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Atezolizumab in combination with bevacizumab for advanced renal cell carcinoma – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Capmatinib for advanced, EGFR wild type, c-Met amplified, non-small cell lung cancer – second or third line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Denosumab (XGEVA) for hypercalcaemia of malignancy – second line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Depatuxizumab mafodotin for recurrent EGFR-amplified glioblastoma multiforme